Takamatsu, Japan
Takamatsu, Japan

Kagawa University is a national university in Takamatsu, Kagawa, Japan. The university was established in 1949 as a national university after the consolidation and reorganization of the Kagawa Normal School, the Kagawa Normal School for Youth and the Takamatsu College of Economics . Wikipedia.


Time filter

Source Type

Patent
Kagawa University and R Technology UENO LTD. | Date: 2016-08-19

Disclosed is a method for treating geographic atrophy associated with age-related macular degeneration in a subject, which comprises administering a 15-keto-prostaglandin compound to the subject in need of the treatment. The 15-keto-prostaglandin compound such as Isopropyl Unoprostone is useful for treating geographic atrophy as well as for preventing vision loss caused by geographic atrophy.


Patent
Kagawa University | Date: 2015-02-24

[Subjects] To provide a biliary tract drainage tube in which both an external drainage tube and an internal drainage tube can be installed in a single endoscopic procedure. [Method to Solve] A biliary tract drainage tube used to drain a biliary tract is provided with long external drainage tube 2 and internal drainage tube 3 that is provided on the tip of the external drainage tube so as to be separable from the external drainage tube. Both external drainage tube 2 and internal drainage tube 3 are placed in biliary tract Cd. Since internal drainage tube 3 can be left behind in the biliary tract by removing external drainage tube 2, another endoscopic procedure is not required when switching from external drainage tube 2 to internal drainage tube 3, and the burden placed on the patient can be lessened.


Patent
Fujitsu Limited and Kagawa University | Date: 2016-07-28

A computer-readable recording medium stores therein an essay creation supporting program that causes a computer to execute a process including: displaying a first screen that includes an object related to one particular affair serving as an essay target and includes a predetermined item related to the one particular affair; receiving, in the first screen being displayed, an instruction operation regarding the predetermined item; and displaying that includes sliding in a second screen, in which a plurality of options regarding a predetermined item corresponding to the received instruction operation is indicated in a selection-input-receivable manner, for display in a screen in which the first screen is displayed, and displaying, on a continuing basis on the screen, the object, which is displayed in the first screen, even during the sliding in and after completion of the sliding in.


Patent
Matsutani Chemical Industry Co. and Kagawa University | Date: 2017-01-11

A method of utilizing the physiological activity of a rare saccharide, wherein physiological-activity sensitive cells are treated with the rare saccharide to modify the function of the cells. A composition containing, as an active ingredient, a rare saccharide which is introduced into physiological-activity sensitive cells and has an effect of modifying the function of the cells. The cells are human cells. The composition is a functional food, a drug, or a cosmetic. The rare saccharide is a rare saccharide belonging to aldose and/or ketose. The aldose is D-allose, and the cells are selected from the group consisting of cancer-cell proliferation inhibitory activity sensitive cells and active-oxygen production inhibitory activity sensitive cells. The ketose is D-psicose, and the cells are selected from the group consisting of chemokine secretion inhibitory activity sensitive cells, microglia migration inhibitory activity sensitive cells, and hypoglycemic activity sensitive cells.


Problem: A malaria transmission blocker or a malaria parasite growth inhibitor is provided as a result of finding a drug which inhibits malaria parasite growth in the body of a vector mosquito. Solution: A malaria parasite growth inhibitor or transmission blocker containing a rare sugar such as D-allose or D-psicose as an active ingredient.


Patent
Kagawa University | Date: 2017-01-11

To provide a tactile sensor that allows a contact to be displaced largely and can detect fine ruggedness, flexibility, and other features of a surface of a measuring object. A sensor part S includes a frame 10 that includes a side part of a substrate B, a contact 20 that is disposed in parallel to the substrate B so that a tip of the contact 20 projects from a side face of the substrate B, a suspension 30 that supports the contact 20 to the frame 10, and displacement detectors 41 and 42 each of which detects displacement of the contact 20. The side face of the substrate B functions as a sensing surface. The contact 20 coming in contact with a measuring object O is displaced on a level parallel to the substrate B. Since the sensor part S can be configured widely in a planar manner along the substrate B, the structure has higher flexibility of design. As a result, the sensor part S allows the contact 20 to be displaced largely, and can detect fine ruggedness, flexibility and other features of the surface of the measuring object O.


Patent
Ochsner Clinic Foundation, Kagawa University and University of Arkansas | Date: 2016-12-22

Fusion proteins containing active agonist or antagonist fragments of parathyroid hormone (PTH) and parathyroid hormone related peptide (PTHrP) coupled to a collagen-binding domain are presented. The fusion proteins can be used to promote bone growth, to promote hair growth, to prevent cancer metastasis to bone, to promote immune reconstitution with a bone marrow stem cell transplant, to promote mobilization of bone marrow stem cells for collection for autologous stem cell transplant, and to treat renal osteodystrophy. Pharmaceutical agents comprising a collagen-binding polypeptide segment linked to a non-peptidyl PTH/PTHrP receptor agonist or antagonist are also presented.


Problem: A malaria transmission blocker or a malaria parasite growth inhibitor is provided as a result of finding a druq which inhibits malaria parasite growth in the body of a vector mosquito. Solution: A malaria parasite growth inhibitor or transmission blocker containinq a rare sugar such as D-allose or D-psicose as an active ingredient.


Patent
Matsutani Chemical Industry Co. and Kagawa University | Date: 2017-06-07

A composition comprising D-allose as an active ingredient for use in the treatment of liver cancer or skin cancer in a patient by administering said composition to said patient.


Patent
University of Arkansas, The Kitasato Institute, Montefiore Medical Center and Kagawa University | Date: 2017-01-17

Methods of delivering therapeutic agents by administering compositions including a bacterial collagen-binding polypeptide segment linked to the therapeutic agent to subjects in need of treatment with the therapeutic agent are provided. In these methods, the therapeutic agent is not a PTH/PTHrP receptor agonist or antagonist, basic fibroblast growth factor (bFGF) or epidermal growth factor (EGF). The bacterial collagen-binding polypeptide segment delivers the agent to sites of partially untwisted or under-twisted collagen. Methods of treating collagenopathies using a composition including a collagen-binding polypeptide and a PTH/PTHrP receptor agonist are also provided. In addition, methods of treating hyperparathyroidism, and hair loss using compositions comprising a collagen binding polypeptide and a PTH/PTHrP receptor agonist are provided. Finally, methods of reducing hair regrowth by administering a composition including a collagen binding polypeptide and a PTH/PTHrP receptor antagonist are provided.

Loading Kagawa University collaborators
Loading Kagawa University collaborators